Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Dutasteride (0.5mg) Tablet
Therapeutic Category
Urology
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Dutatyle Tablet contains Dutasteride (0.5mg), a medication classified under Urology and primarily indicated for the management of benign prostatic hyperplasia (BPH). Dutasteride belongs to a class of drugs known as 5-alpha reductase inhibitors, which work by reducing the size of an enlarged prostate. By inhibiting the conversion of testosterone to dihydrotestosterone (DHT), Dutasteride alleviates symptoms associated with BPH, such as difficulty in urination, frequent urination, and the feeling of incomplete bladder emptying. It also lowers the risk of complications like urinary retention and the need for prostate surgery.
This medication is particularly beneficial for patients experiencing moderate to severe BPH symptoms and is often used as part of a long-term treatment plan to improve quality of life.
Common side effects include decreased libido, impotence, breast tenderness, or enlargement. Rarely, allergic reactions or mood changes may occur.
Dutatyle Tablet is indicated for the treatment of benign prostatic hyperplasia (BPH) in men with an enlarged prostate.
This medication is intended for use in men only and is not recommended for women or children. Pregnant women should avoid handling crushed or broken tablets due to potential risks to a male fetus.
Store in a cool, dry place below 30°C, away from direct sunlight and moisture. Keep out of reach of children.
Composition : Alfuzosin (10mg) + Dutasteride (0.5mg) Tablet
Composition : Dutasteride (0.5mg) Tablet
Composition : Silodosin (8mg) + Dutasteride (0.5mg)
Composition : Silodosin (8mg) + Dutasteride (0.5mg) Capsule
Composition : Ursodeoxycholic Acid (125mg/5ml)
Composition : Ursodeoxycholic Acid (150mg)
Composition : Ursodeoxycholic acid 300 mg syrup
Composition : Ursodeoxycholic Acid (300mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Dutasteride 0.5mg Tablet is widely used in urology and men’s health management, making it a strong prescription product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in benign prostatic hyperplasia (BPH), enlarged prostate management, urinary flow improvement, and male pattern hair loss support. It is commonly prescribed by urologists and physicians for long-term therapy.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Dutasteride 0.5mg Tablet with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from strong chronic prescription demand, long-term therapy usage, and steady repeat sales in urology and men’s health segments when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this urology formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.